{"organizations": [], "uuid": "f170bcb599d63050d915d797f7ad3452ac6e2744", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180504.html", "section_title": "Archive News &amp; Video for Friday, 04 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-grants-paxvax-fast-track-desig/brief-fda-grants-paxvax-fast-track-designation-for-its-chikungunya-vaccine-idUSASC09ZWZ", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Grants PaxVax Fast Track Designation For Its Chikungunya Vaccine", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.64, "site_type": "news", "published": "2018-05-04T20:27:00.000+03:00", "replies_count": 0, "uuid": "f170bcb599d63050d915d797f7ad3452ac6e2744"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-grants-paxvax-fast-track-desig/brief-fda-grants-paxvax-fast-track-designation-for-its-chikungunya-vaccine-idUSASC09ZWZ", "ord_in_thread": 0, "title": "BRIEF-FDA Grants PaxVax Fast Track Designation For Its Chikungunya Vaccine", "locations": [], "entities": {"persons": [{"name": "axvax", "sentiment": "none"}], "locations": [{"name": "chikungunya", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 4 (Reuters) - PaxVax:\n* FDA GRANTS PAXVAX FAST TRACK DESIGNATION FOR ITS CHIKUNGUNYA VACCINE\n* PAXVAX SAYS HAS RECEIVED FAST TRACK DESIGNATION FROM U.S. FDA FOR ITS VACCINE FOR PREVENTION OF DISEASE CAUSED BY CHIKUNGUNYA VIRUS\n* PAXVAX SAYS EXPECTS RESULTS FROM ITS PHASE 2B DOSE-FINDING TRIAL OF CHIKUNGUNYA VLP VACCINE IN EARLY 2019 Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-04T20:27:00.000+03:00", "crawled": "2018-05-05T12:01:07.027+03:00", "highlightTitle": ""}